Found 18 cardiology-waxman trials
A listing of cardiology-waxman medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
PEERLESS II
This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE. Up to 1200 subjects with intermediate-risk acute PE will be randomized. All subjects who sign informed consent and who meet all of the inclusion criteria and none …
Milvexian- ACS study
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel group, event-driven, superiority, group sequential study to evaluate the efficacy and safety of milvexian in participants enrolled within 7 days of an Acute Coronary Syndrome. Participants will receive either milvexian/ placebo on a background of standard-of-care antiplatelet therapy. The total …
DRAIN HF study
This is a prospective, multicenter,randomized, nonblinded study to evaluate the safety and effectiveness of the Aortix System versus standard of care medical therapy in patients hospitalized with ADHF and persistent congestion despite usual medical management and who are not being considered for nearterm advanced HF therapy (i.e., LVAD placement or …
EMPACT-MI
Phase 3
This clinical trial is enrolling participants that have had a heart attack, (also called acute myocardial infarction or MI). Even though treatments have made progress, researchers are still trying to improve care for heart attack patients, who are at increased risk for heart failure and death. The purpose of this …
STRIDE Study : The Effects of semaglutide on functional capacity in pith type 2 diabetes and peripheral arterial disease
Phase 3
This is a 52 week, randomized, double-blind, placebo-controlled trial comparing semaglutide 1 mg versus placebo both added to standard of care and administered once weekly in subjects with Type 2 Diabetes Mellitus with Intermittent Claudication.
RESTART study
Interventional, prospective, single-arm, multicenter clinical investigation. The purpose of this study is to evaluate the additional benefit of targeting specific areas in the heart during a repeat ablation procedure using a new medical decision support software called VX1. Patients with documented atrial fibrillation recurrences who had previous ablation procedure for …
Farapulse Advent Study
This investigation is a prospective, randomized, multi-center IDE pivotal study comparing the FARAPULSE Pulsed Field Ablation System to standard of care RF and cryoballoon ablation in subjects with drug-resistant symptomatic PAF. Subjects with documented drug-resistant (Class I-IV) PAF who have had 2 PAF episodes within 12 months of enrollment will …
AIM HIGHer Clinical Trial
This is a multicenter, randomized, quadruple-blind, sham controlled, 2-part, embedded IDE clinical trial. The main objective is to evaluate the efficacy and safety of Cardiac Contractility Modulation (CCM) therapy in patients with symptomatic HF with LVEF 40-60%. The study is divided into 3 phases, screening, randomization (where 2/3 will be …
INTEGRA-D study
The INTEGRA D study will evaluate the safety and efficacy of the CCM D System in patients with heart failure symptoms despite being on GDMT and have an LVEF 40%.The This is designed as a single arm, prospective, multicenter study of 300 subjects that will establish that the device can …
Attralus AT02-001
To evaluate the safety and tolerability of IV AT-02 in subjects with systemic amyloidosis. To evaluate the clinical activity of AT-02. Cardiac MRI, NYHA functional classification,and echocardiogram. KCCQ-23, 6MWT
1 - 10 of 18
- 1
- 2
